Comparison of Subjective Refraction Measurement With SiVIEW Software and by an Expert
NCT ID: NCT04185701
Last Updated: 2023-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
111 participants
INTERVENTIONAL
2022-11-01
2023-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Show that the equivalent sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Secondary objectives
Show that the sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Show that the cylinder refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Show that the visual acuity measurements obtained by the SiVIEW software do not have a significant clinical difference with those obtained by an optometrist expert.
Demonstrate that the report delivered for each eye exam by SiVIEW software is consistent and relevant to a vision health practitioner.
Show that the differences obtained between two eye examination experts are consistent with those found in the literature.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Ametropia is an eye refractive disorder typically leading to myopia, hyperopia, astigmatism... 4.5 billion people are currently affected worldwide, of whom only 2 billion are corrected. Of these people, about 30% (or +/- 600,000) do not benefit from an adequate correction. From an economic point of view, the cost on productivity of the absence or poor vision correction is estimated at more than 270 billion euros / year worldwide.
Any correction of an ametropic disorder necessarily requires a precise and relevant eye examination in order to identify the disorder and determine the best possible visual correction. The procedure for this examination is identical in all countries. It must follow specific steps\[Benjamin 2006; Grosvenor 2007\].
At present the refraction measurement is done manually by an expert. The optical correction may vary from one examination to another, for multiple physiological and/or examination-related reasons. Several factors can cause fluctuations in subjective refraction. These include examiner and subject characteristics \[Grein et al. 2014\].
In addition, there is also variability due to the measurement itself, depending on each examiner. The repeatability (on the same subject) and, in addition, the reproducibility (inter-examiners) of the subjective refraction measurement related to the examiner's interpretation, examination process and experience, among other things, are therefore important data to be defined in order to know the tolerance of the measurement determined between two examinations.
In studies involving a large number of subjects, the repeatability/reproducibility limit is greater than or equal to 0.71D \[Zadnik 1994, Bullimore 1998, MacKenzie 2008\], and more particularly during inter-examiner measurements.
The objective of the SiVIEW solution is therefore to make the measurement of subjective refraction both repeatable and reproducible regardless of the practitioner and his expertise, by completely automating the search for the best visual prescription using an expert system that aims to make this examination simple, intuitive and reliable.
It is therefore essential to compare the SiVIEW measurement with that of an optometrist expert.
The interest of the investigator's study will be to demonstrate that the results between a refraction expert and the measurement obtained by SiVIEW are clinically similar.
Main objective:
Show that the equivalent sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Secondary objectives
Show that the sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Show that the cylinder refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert.
Show that the visual acuity measurements obtained by the SiVIEW software do not have a significant clinical difference with those obtained by an optometrist expert.
Demonstrate that the report delivered for each eye exam by SiVIEW software is consistent and relevant to a vision health practitioner.
Show that the differences obtained between two eye examination experts are consistent with those found in the literature.
Plan of the study:
It is a comparative prospective open monocentric cross-sectionnal study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
* Eye examination by a technician with the SiVIEW system
* Analysis of the SiVIEW report by the expert who conducted the second review
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eye examination by expert and SiVIEW software
Eye examination by an expert and by a technician with the SiVIEW system.
SiVIEW software
Eye examination by a technician with the SiVIEW software
Expert
Eye examination by an expert including optimal correction in distance and near vision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SiVIEW software
Eye examination by a technician with the SiVIEW software
Expert
Eye examination by an expert including optimal correction in distance and near vision
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subject with normal environmental transparency
* subject with a healthy fundus that does not reveal major abnormalities that may affect vision
* subject able to read the letters of the Latin alphabet
* subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
* non-diabetic subject
* non nystagmic subject
* non-strabic subject
* subject who has not had eye surgery less than 1 year old
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SiVIEW
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Damien Gatinel, MD
Role: PRINCIPAL_INVESTIGATOR
Head of Department Ophthalmological Foundation A. de Rothschild, Paris, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ophthalmological Foundation A. de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SiVIEW_refraction_Paris_study
Identifier Type: -
Identifier Source: org_study_id